With the advent of neuroreceptor and neurotransmission imaging by means of positron emission tomography and single-photon emission computed tomography in vivo, it is now possible to directly record the normal and pathophysiological processes served by monoamines in the brain, as well as to examine the possibilities and potential impact of treatment of disorders of monoaminergic neurotransmission. This article describes the methods of noninvasive brain imaging and the benefits that this imaging can bring to the understanding of disturbed monoaminergic neurotransmission, the mechanisms underlying the disturbances, and the impact of possible therapies.
|Title of host publication||Encyclopedia of Neuroscience|
|Number of pages||14|
|State||Published - 2009|